Key terms
About RLMD
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest RLMD news
Apr 18
11:35am ET
Rising High: Exclusive talk with cannabis market research firm BDSA
Apr 11
10:24am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Apr 04
11:06am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Mar 28
11:32am ET
Rising High: Exclusive talk with financial services firm Safe Harbor Financial
Mar 21
10:52am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Mar 21
2:45am ET
Optimistic Buy Rating for Relmada Therapeutics Amidst Strong Phase 3 Trial Prospects and Financial Stability
Mar 21
2:17am ET
Optimistic Outlook for Relmada Therapeutics: A Comprehensive Analysis and Buy Rating
Mar 19
4:16pm ET
Relmada Therapeutics reports Q4 EPS (84c), consensus (83c)
Mar 19
8:06am ET
Options Volatility and Implied Earnings Moves Today, March 19, 2024
Mar 14
11:15am ET
Rising High: Exclusive talk with cannabis market research firm BDSA
Mar 07
1:09pm ET
Rising High: Exclusive talk with multi-state operator C3 Industries
Mar 07
10:46am ET
Rising High: Exclusive talk with vape tech developer Ispire Technology
Feb 29
11:29am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 29
11:29am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 22
11:19am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 22
11:19am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 15
10:57am ET
Rising High: Exclusive talk with cannabis market research firm BDSA
Feb 15
10:57am ET
Rising High: Exclusive talk with cannabis market research firm BDSA
Feb 08
11:22am ET
Rising High: Exclusive talk with house of brands Carma HoldCo
Feb 08
11:22am ET
Rising High: Exclusive talk with house of brands Carma HoldCo
Feb 05
4:40am ET
Analysts Are Bullish on Top Healthcare Stocks: Immunocore Holdings (IMCR), Thermo Fisher (TMO)
Feb 01
11:35am ET
Rising High: Exclusive talk with drug manufacturer Optimi Health
Feb 01
11:35am ET
Rising High: Exclusive talk with drug manufacturer Optimi Health
Feb 01
11:21am ET
Rising High: Exclusive talk with drug manufacturer Optimi Health
Jan 25
11:09am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Jan 25
11:09am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
No recent press releases are available for RLMD
RLMD Financials
Key terms
Ad Feedback
RLMD Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
RLMD Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
